In-silico study of antisense oligonucleotide antibiotics.

Area of Science:

• Computational Biology
• Antimicrobial Drug Discovery
• Genomics

Background:

• Antibiotic resistance is a growing global health crisis, leading to untreatable infections.
• The development of new antibiotics is hindered by the time-consuming process of determining bacterial protein structures.
• Antisense oligonucleotides (ASOs) offer a novel RNA-based therapeutic platform for antibiotic development.

Purpose of the Study:

• To develop a bioinformatics pipeline for identifying potent antisense oligonucleotide (ASO) targets in essential bacterial genes.
• To facilitate the discovery of new antibiotic candidates by streamlining target identification.

Main Methods:

• Essential bacterial genes from *P. gingivalis*, *H. influenzae*, and *S. aureus* were analyzed.
• A bioinformatics pipeline filtered genes for specificity and accessibility, generating ASO candidates.
• ASO candidates were ranked based on hybridization scores, melting temperature, and operon position.

Main Results:

• The pipeline identified 1,117 putative ASO targets in *P. gingivalis*, 847 in *H. influenzae*, and 7,061 in *S. aureus*.
• Identified targets are associated with critical bacterial processes such as translation and cell division.
• The developed pipeline successfully identified unique and accessible ASO targets in key bacterial pathogens.

Conclusions:

• The bioinformatics pipeline is an effective tool for discovering novel ASO targets against problematic bacterial species.
• This approach can accelerate the development of new antisense oligonucleotide (ASO) antibiotics to combat antimicrobial resistance.